Work Here?
Genesis Therapeutics
Work Here?
AI-driven drug discovery for pharmaceuticals
Genesis Therapeutics
Work Here?
AI-driven drug discovery for pharmaceuticals
About Genesis Therapeutics
Industries
AI & Machine Learning
Biotechnology
Company Size
51-200
Company Stage
Series B
Total Funding
$272.5M
Headquarters
Burlingame, California
Founded
2019
Overview
Genesis Therapeutics focuses on developing new medicines by using artificial intelligence in the drug discovery process. The company employs a method that combines 3D spatial graph modeling and advanced molecular simulation to identify potential drug candidates. This approach enables them to explore new chemical spaces and discover novel protein targets, which can lead to important new medicines. Unlike many competitors, Genesis Therapeutics operates on a business-to-business model, partnering with other biotech and pharmaceutical companies, such as Eli Lilly, to provide their AI-driven drug discovery services. Their goal is to accelerate the development of new drugs through strategic partnerships and successful collaborations.
Simplify's Take
What believers are saying
- Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.
- $224 million equity investment boosts research and development capabilities.
- Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.
What critics are saying
- Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.
- Over-reliance on partnerships could lead to financial instability if drugs aren't successful.
- Rapid AI advancements may render current models like GEMS obsolete without updates.
What makes Genesis Therapeutics unique
- Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.
- The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.
- Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$272.5M
Above
Industry Average
Funded Over
3 Rounds
Andreessen HorowitzIndustry standards
Benefits
Competitive salary
Equity
Medical, dental, & vision insurance
401(k) program
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↑ 3%2 year growth
↑ 0%Nvidia’s venture arm, NVentures, has increased its investment in AI drug discovery firm Genesis Therapeutics. Genesis, founded by Evan Feinberg, has raised over $300 million, including a $200 million Series B in 2023. The collaboration aims to enhance Genesis' AI platform, GEMS, for drug discovery. Genesis is also working with Gilead, Eli Lilly, and Genentech on various projects. The company plans to expand its workforce beyond its current 80 employees.
Genesis Therapeutics receives equity investment from NVIDIA.
Genesis Therapeutics has partnered with NVIDIA to enhance its AI platform, GEMS, for drug discovery. This collaboration is supported by additional funding from NVentures, NVIDIA's venture capital arm, following its participation in Genesis' $200 million Series B financing in August 2023. The partnership aims to optimize computational methods like equivariant neural networks to analyze complex 3D molecular structures, targeting diseases with high unmet needs and previously undruggable targets.
Gilead Sciences (GILD) and Genesis Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets.
Gilead and Genesis Therapeutics announce strategic collaboration to discover and develop novel therapies.
Genesis Therapeutics is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Genesis Therapeutics
Industries
AI & Machine Learning
Biotechnology
Company Size
51-200
Company Stage
Series B
Total Funding
$272.5M
Headquarters
Burlingame, California
Founded
2019
Genesis Therapeutics is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today